Custom R&D Collaboration for Cardiovascular Pharmaceutical Intermediates
A well-known pharmaceutical company urgently needed high-purity cardiovascular pharmaceutical intermediates to advance the development of a new antihypertensive drug. Leveraging its in-house R&D team, the company conducted customized technical research tailored to the client's needs, completing process optimization and pilot production of the target intermediate within three months, achieving a purity of 99.8%. Subsequent large-scale production support helped the pharmaceutical company smoothly advance its new drug clinical trials. This led to the establishment of a long-term strategic partnership with an annual value exceeding 20 million yuan.
Related Picks
The economic operation of the petrochemical industry in the first half of the year showed six major characteristicsOct 20 2025Recently, reporters learned at the 2025 National Petroleum and Chemical Industry Economic Situation Analysis Conference held in Nantong, Jiangsu that the economic operation of the petrochemical industry was basically stable in the first half of this year, showing six major characteristics.
In July, the added value of chemical raw materials and chemical products manufacturing increased by 7.2% year-on-yearOct 20 2025Recently, the National Bureau of Statistics released data showing that in July, the added value of industrial enterprises above designated size increased by 5.7% year-on-year in real terms. Among them, the oil and natural gas extraction industry increased by 4.1% year-on-year, and the chemical raw materials and chemical products manufacturing industry increased by 7.2% year-on-year.
Connecting with over 4,000 factories, a company launches a one-stop procurement service for chemical products.Sep 30 2025To address the pain points of high procurement costs and time-consuming procurement processes for customers, a company has integrated industry resources and established strategic partnerships with over 4,000 factories, providing one-stop procurement services for nearly 50,000 chemical products.
Covering Seven Therapeutic Areas! A Company's Pharmaceutical Intermediates Product Range Exceeds 330 CategoriesSep 30 2025A company deeply engaged in the pharmaceutical intermediates sector has achieved further success. Its pharmaceutical intermediates now cover seven therapeutic areas: anti-infectives, cardiovascular and cerebrovascular systems, digestive system, anti-tumor, neurological, geriatric, and gynecological medications, with a product range exceeding 330 categories.
Question Consultation
Send Us Your Inquiry Today
Whether you have inquiries about product specifications, pricing, delivery, or customized solutions, please leave us a detailed message. Our professional sales and technical team will respond to you promptly and provide one-stop support for your global procurement.